Progressive Care Schedules Investor Conference Call for May 15th, 2018

It’s been a very eventful and very successful three months…,” stated S. Parikh Mars, CEO. “We respect the importance of open communication, and enjoy keeping investors up to date on Company developments through these ongoing quarterly calls.” On the call, S. Parikh Mars, Progressive Care Inc. CEO, will address:
• An overview of the Company’s Q1 2018 financial results
• Company and industry trends and developments
• Status updates on 2018 initiativesTo access the call:
Dial-In Number: 1-857-232-0157
Access Code: 422095
In addition, interested parties have the opportunity to submit questions concerning the Company prior to the call to Stuart Smith at SmallCapVoice.Com, Inc. via email: ssmith@smallcapvoice.com by 3:00 PM eastern standard time on Monday, May, 14th, 2018. Mr. Smith will compile a list of questions and submit them to the Company prior to the conference call. Which questions will be addressed will be based on the relevance to the shareholder base, and the question’s appropriateness in light of public disclosure rules.

 


Disclosure & Financial Reports

PublishedTitlePeriod EndStatus
05/14/2018Quarterly Report - CONSOLIDATED FINANCIAL STATEMENTS FOR THE QUARTER ENDED MARCH 31, 2018 (UNAUDITED)03/31/2018A
03/30/2018Officer/Director/Affiliate Stock Transactions - Officer/Director/Affiliate Stock Transactions03/30/2018A
03/30/2018Notice of Change in Substantial Holder Interest - Notice of Change in Substantial Holder Interest03/30/2018A
03/21/2018Annual Report - CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEAR ENDED DECEMBER 31, 2017 (AUDITED)12/31/2017A
11/14/2017Quarterly Report - CONSOLIDATED FINANCIAL STATEMENTS FOR THE QUARTER ENDED SEPTEMBER 30, 2017 (UNAUDITED)09/30/2017A
10/25/2017OTCQB Certification - OTCQB Certification12/31/2016A
08/14/2017Quarterly Report - Quarterly Report - CONSOLIDATED FINANCIAL STATEMENTS FOR THE QUARTER ENDED JUNE 30, 2017 (UNAUDITED)06/30/2017A
05/15/2017Quarterly Report - CONSOLIDATED FINANCIAL STATEMENTS FOR THE QUARTER ENDED MARCH 31, 2017 (UNAUDITED)03/31/2017A
03/31/2017Annual Report - CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEAR ENDED DECEMBER 31, 2016 (AUDITED)12/31/2016A
11/21/2016Quarterly Report - ONSOLIDATED FINANCIAL STATEMENTS FOR THE QUARTER ENDED SEPTEMBER 30, 2016 (UNAUDITED)09/30/2016A
11/11/2016Notification of Late Filing - Quarterly Report September 30, 201609/30/2016A
08/15/2016Quarterly Report - CONSOLIDATED FINANCIAL STATEMENTS FOR THE QUARTER ENDED JUNE 30, 2016 (UNAUDITED)06/30/2016A
05/15/2016Quarterly Report - CONSOLIDATED FINANCIAL STATEMENTS FOR THE QUARTER ENDED MARCH 31, 2016 (UNAUDITED)03/31/2016A

Headlines

Progressive Care Inc. Garners International News Coverage in Leading Trade Publications for Its Efforts to Improve Adherence

Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced that it has garnered notable international media coverage in top pharmacy industry publication World Pharma Today stressing the importance of adherence and compliance in the space of medicine. In a contributed article titled “The Pharmacist Perspective: Medication Adherence & Compliance”, published November 26, 2018, in World Pharma Today, Mars focuses on adherence and its significance for patients who are prescribed medications.

Tue, 04 Dec 2018 13:00:00 +0000

Progressive Care Signs Letter of Intent to Purchase Florida Based Pharmacy with $18 million in Annual Revenue

Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced that it has entered into a letter of intent to purchase a Florida based pharmacy with 2 operating locations. On November 27, 2018, Progressive Care executed a letter of intent to purchase a Florida based pharmacy with locations in Davie and Orlando, Florida. The target pharmacy had just under $16 million in revenue in 2017 and is projected to have approximately $18 million for 2018.

Wed, 28 Nov 2018 13:00:00 +0000

Progressive Care Inc. Announces Record-Breaking October 2018

MIAMI, Nov. 16, 2018 -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced further growth year-over-year in revenue.

Fri, 16 Nov 2018 13:00:00 +0000

Progressive Care Inc. Reports Best Nine-Month Revenue Period in Company History in Q3 2018 Financial Filing

Progressive Care Inc. (RXMD), a personalized healthcare services and technology company, today announced financial results for the quarter ending Sept. 30, 2018, as well as provided an overview of recent operational highlights along with updates on the Company’s strategies. Progressive Care dispensed 212,000 prescriptions during the nine-month period ending Sept. 30, 2018, an increase over the same period last year of 30%. During Q3 2018, the Company experienced continued growth over last year, showing a 6% increase in total revenue over Q3 2017.

Thu, 15 Nov 2018 13:00:00 +0000

Progressive Care to Host Conference Call on Third Quarter 2018 Financial Results and Business Update on November 14th

Progressive Care Inc. (RXMD), a personalized healthcare services and technology company, is pleased to announce that the Company has scheduled an investor conference call at 4:30 PM ET on Wednesday, November 14th, 2018. “I am excited to share the significant milestones that Progressive Care and our subsidiary PharmCo have experienced in the most recent quarter with our engaged investors and the public,” said S. Parikh Mars, CEO of Progressive Care Inc. “The company is experiencing an extremely positive outlook and growth trajectory and I couldn’t be more proud of our progress in Q3 and the year to date. In addition, interested parties have the opportunity to submit questions concerning the Company prior to the call to Stuart Smith at SmallCapVoice.Com, Inc. via email: ssmith@smallcapvoice.com by 3:00 PM eastern standard time on Monday, November, 12th, 2018.

Fri, 09 Nov 2018 13:00:00 +0000

Progressive Care Inc. CEO to Speak at 5th Annual Florida Telehealth Summit in St. Pete Beach, Florida

MIAMI, Nov. 01, 2018 -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced that the company will be attending and.

Thu, 01 Nov 2018 13:00:00 +0000

Progressive Care Enters into Definitive Agreements to Purchase Property for Third Pharmacy Location in South Florida

Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, today announced that through its subsidiary Pharmco, LLC, it has entered into definitive agreement (the “Agreement”) to purchase a property in Broward County, Florida that will double as the new corporate headquarters and as a retail pharmacy. This third location will facilitate the Company’s growth by expanding the Company’s pharmacy operations in the South Florida region.

Tue, 30 Oct 2018 13:00:00 +0000

Progressive Care Inc. Announces Beta Launch of New Proprietary Tele-PharmCo Software Platform for Real-Time Patient-to-Pharmacist Video Interactions

Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced the beta launch of its new proprietary tele-pharmacy software Tele-PharmCo. The new multi-platform technology software will facilitate two-way video conferencing between patients, healthcare professionals, and PharmCo’s team of pharmacists and pharmacy technicians through a secure video interface. Tele-PharmCo will allow patients and their care providers to connect and interact with licensed pharmacists and pharmacy technicians in real-time and speak directly about medications, prescription refills, adverse reactions, and other concerns.

Thu, 18 Oct 2018 12:02:00 +0000

Progressive Care Inc. Announces 40% Year-Over-Year Increase in Prescriptions Filled and Continued Strong Revenues in September 2018

Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced further growth year-over-year in both revenue and number of prescriptions filled for September 2018. In September, the company reported a total of $1.6 million in net revenue, a 7% increase from the same month last year, and a 40% increase in prescriptions filled during the same month last year, totaling more than 24,300 filled prescriptions. Progressive Care’s wholly-owned subsidiary PharmCo, LLC saw a record month for prescriptions filled in September, reporting a 23% increase in prescriptions filled over the same month last year, totaling more than 21,350 prescriptions.

Tue, 16 Oct 2018 12:00:00 +0000

Progressive Care Inc. Announces Record Number of Prescriptions Filled and Strong Revenues During August 2018

Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced further growth year-over-year in both revenue and number of prescriptions filled for August 2018. In August, the company reported a total of $1.93 million in net revenue, a 3% increase from the same month last year, and a 44% increase in prescriptions filled during the same month last year, totaling just over 29,000 filled prescriptions. Progressive Care’s wholly-owned subsidiary PharmCo, LLC saw a record month for prescriptions filled in August, reporting a 30% increase in prescriptions filled over the same month last year, totaling more than 26,200 prescriptions.

Tue, 18 Sep 2018 12:00:00 +0000

Progressive Care Inc. Garners International News Coverage in Top Pharmacy Trade Publication for Its Efforts to Battle Opioid Epidemic

Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced that it has garnered notable international media coverage in top pharmacy industry publication World Pharma Today around the company’s efforts to combat the nationwide opioid epidemic. In a contributed article published August 20, 2018, in World Pharma Today, Mars explores the history of the opioid crisis and shares her perspective on what more can be done to provide patients with better access to pain management alternatives in lieu of prescription opioid medications.

Wed, 12 Sep 2018 12:00:00 +0000